Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Prospective, Randomized, Controlled, Open-label, Parallel Study to Evaluate the Safety and Efficacy of the Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

NCT03257410 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT03257410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03257410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Prospective, Randomized, Controlled, Open-label, Parallel Study to Evaluate the Safety and Efficacy of the Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
September 29, 2017
Completion date
October 27, 2018
Enrollment
172 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease